Icon (ICLR) Competitors $166.44 -2.75 (-1.63%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$166.46 +0.02 (+0.01%) As of 08/1/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICLR vs. MEDP, CRL, IQV, TMO, WCN, TCOM, RDDT, TOST, CPAY, and GIBShould you be buying Icon stock or one of its competitors? The main competitors of Icon include Medpace (MEDP), Charles River Laboratories International (CRL), IQVIA (IQV), Thermo Fisher Scientific (TMO), Waste Connections (WCN), Trip.com Group (TCOM), Reddit (RDDT), Toast (TOST), Corpay (CPAY), and CGI Group (GIB). Icon vs. Its Competitors Medpace Charles River Laboratories International IQVIA Thermo Fisher Scientific Waste Connections Trip.com Group Reddit Toast Corpay CGI Group Medpace (NASDAQ:MEDP) and Icon (NASDAQ:ICLR) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations and institutional ownership. Is MEDP or ICLR more profitable? Medpace has a net margin of 18.74% compared to Icon's net margin of 9.82%. Medpace's return on equity of 67.66% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Medpace18.74% 67.66% 21.86% Icon 9.82%10.95%6.23% Which has higher valuation & earnings, MEDP or ICLR? Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedpace$2.11B5.64$404.39M$13.4531.46Icon$8.28B1.62$791.47M$9.7217.12 Does the media prefer MEDP or ICLR? In the previous week, Medpace had 31 more articles in the media than Icon. MarketBeat recorded 43 mentions for Medpace and 12 mentions for Icon. Medpace's average media sentiment score of 0.83 beat Icon's score of 0.74 indicating that Medpace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 25 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Icon 4 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, MEDP or ICLR? Medpace has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. Comparatively, Icon has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Do analysts prefer MEDP or ICLR? Medpace presently has a consensus price target of $406.60, indicating a potential downside of 3.90%. Icon has a consensus price target of $219.54, indicating a potential upside of 31.90%. Given Icon's stronger consensus rating and higher probable upside, analysts plainly believe Icon is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medpace 3 Sell rating(s) 9 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.93Icon 0 Sell rating(s) 5 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 2.81 Do institutionals and insiders have more ownership in MEDP or ICLR? 78.0% of Medpace shares are owned by institutional investors. Comparatively, 95.6% of Icon shares are owned by institutional investors. 20.3% of Medpace shares are owned by insiders. Comparatively, 44.0% of Icon shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryMedpace beats Icon on 9 of the 17 factors compared between the two stocks. Get Icon News Delivered to You Automatically Sign up to receive the latest news and ratings for ICLR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ICLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICLR vs. The Competition Export to ExcelMetricIconMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.66B$7.18B$5.49B$9.52BDividend YieldN/A2.90%4.73%4.09%P/E Ratio17.1264.1328.7823.81Price / Sales1.6233.83372.2066.04Price / Cash8.4425.7735.4557.96Price / Book1.418.618.275.54Net Income$791.47M$239.96M$3.25B$259.28M7 Day Performance-11.00%-5.48%-3.70%-4.64%1 Month Performance10.36%-3.73%4.34%4.41%1 Year Performance-47.51%18.27%25.90%17.95% Icon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICLRIcon4.5302 of 5 stars$166.44-1.6%$219.54+31.9%-49.1%$13.66B$8.28B17.1241,900MEDPMedpace4.1786 of 5 stars$453.05+1.2%$411.10-9.3%+9.8%$12.57B$2.11B33.685,900Analyst DowngradeInsider TradeCRLCharles River Laboratories International4.3044 of 5 stars$179.10+1.2%$174.54-2.5%-31.3%$8.69B$4.05B-275.5420,100Positive NewsUpcoming EarningsIQVIQVIA4.8547 of 5 stars$197.73-0.7%$228.62+15.6%-26.5%$33.86B$15.41B28.6288,000Positive NewsTMOThermo Fisher Scientific4.9941 of 5 stars$484.90+1.4%$593.00+22.3%-25.6%$180.56B$42.88B28.05125,000Positive NewsAnalyst UpgradeWCNWaste Connections4.4585 of 5 stars$186.07-0.5%$215.00+15.5%+4.4%$48.31B$8.92B75.0323,854Short Interest ↑TCOMTrip.com Group4.8089 of 5 stars$63.50-1.4%$77.25+21.7%+47.4%$42.09B$7.30B19.7041,073News CoverageRDDTReddit3.0897 of 5 stars$151.81+1.4%$143.08-5.7%+217.6%$27.62B$1.30B253.662,233Trending NewsEarnings ReportAnalyst ForecastGap UpTOSTToast2.6959 of 5 stars$49.00+0.6%$43.17-11.9%+85.1%$24.25B$4.96B202.925,700Positive NewsUpcoming EarningsAnalyst ForecastGap DownCPAYCorpay3.9611 of 5 stars$333.69-0.6%$401.07+20.2%+11.0%$23.68B$3.97B18.3911,200Positive NewsUpcoming EarningsGap DownGIBCGI Group3.8854 of 5 stars$99.80-1.3%$156.75+57.1%-14.5%$22.69B$10.79B18.1890,250Trending NewsEarnings ReportDividend IncreaseAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies MEDP Alternatives CRL Alternatives IQV Alternatives TMO Alternatives WCN Alternatives TCOM Alternatives RDDT Alternatives TOST Alternatives CPAY Alternatives GIB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICLR) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Icon Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Icon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
